反応式
[CH2:1]([C:5]1[NH:6][C:7](=[O:10])[CH2:8][N:9]=1)[CH2:2][CH2:3][CH3:4].O=P(Cl)(Cl)[Cl:13].CN(C)[CH:18]=[O:19].[OH-].[Na+]>ClC1C=CC=CC=1.C(OCC)(=O)C>[CH2:1]([C:5]1[NH:6][C:7]([Cl:13])=[C:8]([CH:18]=[O:19])[N:9]=1)[CH2:2][CH2:3][CH3:4].[CH2:1]([C:5]1[NH:6][C:7](=[O:10])[CH2:8][N:9]=1)[CH2:2][CH2:3][CH3:4]参加物
反応物 4
生成物 2
試薬・触媒・溶媒 2
反応条件
- 温度
- 100 °C
実験手順
2-n-Butyl-2-imidazolin-5-one (9.81 g, 70 mmol) was added to a solution of phosphoroxychloride (26.83 g, 175 mmol) in chlorobenzene (50 ml) at room temperature. The orange suspension was heated to 100° C. within 5 minutes, and then N,N-dimethylformamide (12.79 g, 175 mmol) was added within 3 minutes. The black mixture was kept for 2 hours at 100° C., cooled to 40° C. and poured on water (84 ml). After addition of ethyl acetate (42 ml), the mixture was stirred for 15 minutes at 26° to 28° C. and then adjusted to pH 7 by addition of 30 percent sodium hydroxide solution (67 ml). The phases were separated, and the aqueous phase was extracted twice with 70 ml of ethyl acetate each. The combined organic phases were dried (MgSO4), filtered and concentrated by evaporation on a Rotavapor. The title compound was obtained in a yield of 8.31 g (64 percent) relative to the 2-n-butyl-2-imidazolin-5-one.
後処理
- temperaturecooled to 40° C.
- additionpoured on water (84 ml)
- customThe phases were separated
- extractionthe aqueous phase was extracted twice with 70 ml of ethyl acetate each
- dry with materialThe combined organic phases were dried (MgSO4)
- filtrationfiltered
- concentrationconcentrated by evaporation on a Rotavapor
出典と根拠
- ORDレコード
- ord-d85c9d827bb94bcc9444f870b63b5a3a
- 出典データセット
- uspto-grants-1995_08
- 特許番号
- US05442075
関連ノート
読み込み中…